Latest 10-K annual reports

Knightscope, a security technology firm, reported a 5% revenue increase to $11.3 million in 2025, alongside a widened net loss of $33.8 million, while completing a significant acquisition to bolster its integrated security platform.

Tenon Medical, Inc. reported increased revenue for 2025 but continues to face significant operating losses, a going concern doubt, and a Nasdaq delisting notice due to its low bid price.

Crown Reserve Acquisition Corp. I, a SPAC, reported a net income of $1.13 million for 2025, primarily from trust account dividends, as it continues its search for a business combination.

Launchpad Cadenza Acquisition Corp I filed its annual 10-K report, outlining its SPAC structure, IPO details, target industries, and the ongoing search for a business combination.

Abony Acquisition Corp. I's 10-K filing outlines its blank check company structure, recent IPO, and plans to pursue a business combination in defense tech, advanced computing, software, and media sectors.

Functional Brands Inc. reports a Nasdaq listing, new health platform launch, but faces delisting risk and internal control weaknesses.

1606 Corp. pivots from AI chatbots to power infrastructure and data centers, announcing a major Texas acquisition while grappling with significant financing challenges and a going concern warning.

SPACSphere Acquisition Corp. filed its 10-K, detailing its recent $172.5 million IPO, private placement, and ongoing search for a business combination target by May 2027.

PAVmed Inc. reports significant financial restructuring, including a reverse stock split and capital raises, while advancing its medical device and diagnostics portfolio amidst ongoing operating losses.

Soulpower Acquisition Corp. files its annual 10-K, outlining its proposed business combination with SWB LLC to form Soul World Bank and detailing its financial position as a SPAC.

Presidio Property Trust reports significant asset dispositions, a reverse stock split, and the suspension of Series D Preferred Stock dividends amidst substantial property impairments and a net loss for 2025.

BioXcel Therapeutics reported significant operating losses and declining product revenue for 2025, raising substantial doubt about its ability to continue as a going concern, despite positive clinical trial data for IGALMI's at-home use and ongoing capital raises.

Alussa Energy Acquisition Corp. II, a blank check company, filed its annual 10-K report for 2025, detailing its initial public offering, financial position, and ongoing search for a business combination in the energy sector.

Calidi Biotherapeutics reported significant losses and expressed substantial doubt about its ability to continue as a going concern, despite advancing its RedTail platform and securing recent financings.

Manhattan Bridge Capital reported a decrease in 2025 net income and revenue, while successfully extending key credit facilities and continuing its share repurchase program.

GD Culture Group Limited reported a significant net loss of $186.9 million for fiscal year 2025, primarily due to unrealized losses on Bitcoin holdings, while strategically transitioning its core business to AI-driven interactive reading and narrative entertainment.

Hoth Therapeutics, Inc. reported a significant increase in net loss for 2025, alongside a going concern warning from its auditors, despite progress in its clinical pipeline and substantial capital raises.

Bank of the James Financial Group reports significant increases in net income, total assets, and net interest margin for fiscal year 2025, driven by strategic growth and cost management.

Vine Hill Capital Investment Corp. announces a definitive business combination agreement with CoinShares International Limited, valuing CoinShares at $1.2 billion, subject to shareholder and regulatory approvals.

Healthier Choices Management Corp. reports recurring net losses and a going concern warning, despite debt restructuring and a new credit facility, following its grocery business spin-off.

Verde Clean Fuels, Inc. has suspended its Permian Basin Project and adopted a capital-lite strategy, focusing on technology licensing amid continued net losses and management changes.

Humacyte, Inc. commenced U.S. commercial sales of its FDA-approved Symvess for vascular trauma in Q1 2025, generating $1.4 million in revenue, but faces substantial doubt about its ability to continue as a going concern.

Muzero Acquisition Corp. details its blank check company structure, successful IPO, and ongoing search for a technology-enabled business combination, with a particular interest in the AI sector.

Empery Digital Inc. has pivoted to a digital asset treasury strategy, divesting its four-wheel vehicle business, but reported a substantial net loss of $150.1 million in 2025, largely due to unrealized Bitcoin losses.

Fennec Pharmaceuticals announced record net product sales of $44.6 million for fiscal year 2025, a 50% increase year-over-year, alongside the full redemption of its outstanding debt.

Dillard's, Inc. reported net income of $570.2 million for fiscal year 2025, maintaining gross margins and returning significant cash to shareholders despite flat retail sales.

Northpointe Bancshares, Inc. announced a significant increase in net income and asset growth for 2025, driven by strategic repositioning and expansion in its Mortgage Purchase Program and All-in-One loan segments.

GSR IV Acquisition Corp., a blank check company, reported a net income of $2.32 million for the year ended December 31, 2025, primarily from trust account interest, as it continues its search for a business combination.

Lifeloc Technologies, Inc. reported a significantly increased net loss for fiscal year 2025, driven by strategic investments in its SpinDetect platform and higher interest expenses, despite a modest revenue increase.

Avidia Bancorp recorded a net loss of $3.3 million in 2025, primarily driven by a significant $19.2 million land loan charge-off, despite an 18.1% increase in net interest income and a substantial capital boost from its initial public offering.